383 related articles for article (PubMed ID: 35110452)
1. [The New Generation of Particle Therapy Focused on Boron Element (Boron Neutron Capture Therapy; BNCT) -The World's First Approved BNCT Drug].
Nakashima H
Yakugaku Zasshi; 2022; 142(2):155-164. PubMed ID: 35110452
[TBL] [Abstract][Full Text] [Related]
2. [Current Status of Accelerator-Based Boron Neutron Capture Therapy (BNCT)].
Tanaka H
Igaku Butsuri; 2021; 41(3):117-121. PubMed ID: 34744121
[TBL] [Abstract][Full Text] [Related]
3. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
[TBL] [Abstract][Full Text] [Related]
4. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality.
Barth RF; Zhang Z; Liu T
Cancer Commun (Lond); 2018 Jun; 38(1):36. PubMed ID: 29914575
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (
Hirose K; Konno A; Hiratsuka J; Yoshimoto S; Kato T; Ono K; Otsuki N; Hatazawa J; Tanaka H; Takayama K; Wada H; Suzuki M; Sato M; Yamaguchi H; Seto I; Ueki Y; Iketani S; Imai S; Nakamura T; Ono T; Endo H; Azami Y; Kikuchi Y; Murakami M; Takai Y
Radiother Oncol; 2021 Feb; 155():182-187. PubMed ID: 33186684
[TBL] [Abstract][Full Text] [Related]
6. Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy.
Hattori Y; Andoh T; Kawabata S; Hu N; Michiue H; Nakamura H; Nomoto T; Suzuki M; Takata T; Tanaka H; Watanabe T; Ono K
J Radiat Res; 2023 Nov; 64(6):859-869. PubMed ID: 37717596
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy for malignant brain tumors.
Miyatake SI; Wanibuchi M; Hu N; Ono K
J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
[TBL] [Abstract][Full Text] [Related]
10. Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma.
Kanno H; Nagata H; Ishiguro A; Tsuzuranuki S; Nakano S; Nonaka T; Kiyohara K; Kimura T; Sugawara A; Okazaki Y; Takae S; Nakabayashi T; Arai H; Suzuki H
Oncologist; 2021 Jul; 26(7):e1250-e1255. PubMed ID: 33928712
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
12. The basis and advances in clinical application of boron neutron capture therapy.
He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor.
Wang LW; Liu YH; Chou FI; Jiang SH
Cancer Commun (Lond); 2018 Jun; 38(1):37. PubMed ID: 29914577
[TBL] [Abstract][Full Text] [Related]
14. Influence of Neutron Sources and 10B Concentration on Boron Neutron Capture Therapy for Shallow and Deeper Non-small Cell Lung Cancer.
Yu H; Tang X; Shu D; Liu Y; Geng C; Gong C; Hang S; Chen D
Health Phys; 2017 Mar; 112(3):258-265. PubMed ID: 28121726
[TBL] [Abstract][Full Text] [Related]
15. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Ahmad T; Barth RF; Kabalka GW
J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
[TBL] [Abstract][Full Text] [Related]
17. Fluorinated borono-phenylalanine for optimizing BNCT: Enhancing boron absorption against hydrogen scattering for thermal neutrons.
Romanelli G; Capuani S; Onorati D; Ulpiani P; Preziosi E; Andreani C; Senesi R
Med Phys; 2024 Jan; 51(1):439-446. PubMed ID: 37956252
[TBL] [Abstract][Full Text] [Related]
18. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.
Porra L; Wendland L; Seppälä T; Koivunoro H; Revitzer H; Tervonen J; Kankaanranta L; Anttonen A; Tenhunen M; Joensuu H
Cancer Biother Radiopharm; 2023 Apr; 38(3):184-191. PubMed ID: 36269660
[TBL] [Abstract][Full Text] [Related]
19. Boron delivery agents for neutron capture therapy of cancer.
Barth RF; Mi P; Yang W
Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
[TBL] [Abstract][Full Text] [Related]
20. One step synthesis of
Kuthala N; Shanmugam M; Yao CL; Chiang CS; Hwang KC
Biomaterials; 2022 Nov; 290():121861. PubMed ID: 36302304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
